结缔组织疾病心脏损害的磁共振诊断价值及研究进展

王进; 杨志刚; 郭应坤; 许华燕; 师轲; 李媛

doi:10.13201/j.issn.1001-1439.2021.03.019

结缔组织疾病心脏损害的磁共振诊断价值及研究进展

- 1. 四川大学华西医院放射科(成都, 610041);
- 2. 四川大学华西第二医院放射科出生缺陷与相关妇儿疾病教育部重点实验室
基金项目:
四川大学华西医院学科卓越发展1·3·5工程项目(No:ZYGD18013)

详细信息

通讯作者: 李媛,E-mail:dr.liyuan@163.com

中图分类号: R445.2

收稿日期: 2020-08-20

修回日期: 2020-12-15

The diagnostic value and research advance of magnetic resonance imaging in connective tissue disease with cardiac injury

- 1. Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, China;
- 2. Department of Radiology, West China Second Hospital, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education

More Information

Corresponding author: LI Yuan, E-mail: dr.liyuan@163.com

Received Date: 20 August 2020

Revised Date: 15 December 2020

摘要

摘要: 结缔组织疾病(CTD)是一大类因自身免疫机制失调所致的慢性炎症性免疫性疾病,可累及全身多系统、多器官,包括心脏。心脏各种结构在CTD多种病理生理机制共同作用下均可受累,并以亚临床损害多见。临床上,CTD患者一旦出现心力衰竭,往往提示预后不良。心脏磁共振是一种非侵入性、可重复性强的成像技术,在评价CTD患者心脏形态及功能、心肌水肿、微循环灌注及心肌纤维化方面提供了重要的临床价值。本文就心脏磁共振在CTD患者心脏损害中的诊断价值及研究进展予以综述。
- 结缔组织疾病 /
- 磁共振成像 /
- 诊断
Abstract: Connective tissue disease(CTD) represents a heterogeneous group of chronic inflammatory autoimmune disorders derived from an auto-immunological deregulation and characterized by multisystem and multiorgan involvement, including the heart. Various cardiac structures can be affected by multiple pathophysiological mechanisms of CTD, and subclinical cardiac damage is more common. Once it becomes heart failure clinically, patients may present with a poor prognosis. Cardiac magnetic resonance(CMR) is a non-invasive and highly reproducible imaging technique that provides important clinical value in evaluating cardiac morphology and function, myocardial edema, microcirculation perfusion, and myocardial fibrosis in CTD patients. This review focuses on the diagnostic value and research progress of CMR in CTD patients with the cardiac injury.
- connective tissue disease /
- magnetic resonance imaging /
- diagnosis

HTML全文

参考文献(29)

[1]	Fernandez AP.Connective tissue disease:current concepts[J].Dermatol Clin,2019,37(1):37-48.
[2]	Prasad M,Hermann J,Gabriel SE,et al.Cardiorheumatology:cardiac involvement in systemic rheumatic disease[J].Nat Rev Cardiol,2015,12(3):168-176.
[3]	Mavrogeni SI,Markousis-Mavrogenis G,Koutsogeorgopoulou L,et al.Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases[J].Heart Fail Rev,2019,24(4):489-498.
[4]	Manes MT,Guzzo D,Rizzo M,et al.Cardiovascular disease in early collagen diseases[J].Minerva Cardioangiol,2006,54(1):151-158.
[5]	Mavrogeni SI,Kitas GD,Dimitroulas T,et al.Cardiovascular magnetic resonance in rheumatology:Current status and recommendations for use[J].Int J Cardiol,2016,217:135-148.
[6]	郑顺文,仇兴标.系统性红斑狼疮合并冠心病的临床特点及治疗现状[J].临床心血管病杂志,2019,35(5):473-475.
[7]	Smolenska Z,Barraclough R,Dorniak K,et al.Cardiac involvement in systemic sclerosis:diagnostic tools and evaluation methods[J].Cardiol Rev,2019,27(2):73-79.
[8]	Jain D,Halushka MK.Cardiac pathology of systemic lupus erythematosus[J].J Clin Pathol,2009,62(7):584-592.
[9]	Mavrogeni S,Dimitroulas T,Sfikakis PP,et al.Heart involvement in rheumatoid arthritis:multimodality imaging and the emerging role of cardiac magnetic resonance[J].Semin Arthritis Rheum,2013,43(3):314-324.
[10]	Castaneda S,Gonzalez-Juanatey C,Gonzalez-Gay MA.Inflammatory arthritis and heart disease[J].Curr Pharm Des,2018,24(3):262-280.
[11]	Mavrogeni SI,Sfikakis PP,Koutsogeorgopoulou L,et al.Cardiac tissue characterization and imaging in autoimmune rheumatic diseases[J].JACC Cardiovasc Imaging,2017,10(11):1387-1396.
[12]	Jayakumar D,Zhang R,Wasserman A,et al.Cardiac manifestations in idiopathic inflammatory myopathies:an overview[J].Cardiol Rev,2019,27(3):131-137.
[13]	Mavrogeni S,Markousis-Mavrogenis G,Koutsogeorgopoulou L,et al.Cardiovascular magnetic resonance imaging:clinical implications in the evaluation of connective tissue diseases[J].J Inflamm Res,2017,10:55-61.
[14]	Mauger C,Gilbert K,Lee AM,et al.Right ventricular shape and function:cardiovascular magnetic resonance reference morphology and biventricular risk factor morphometrics in UK Biobank[J].J Cardiovasc Magn Reson,2019,21(1):41.
[15]	Giles JT,Malayeri AA,Fernandes V,et al.Left ventricular structure and function in patients with rheumatoid arthritis,as assessed by cardiac magnetic resonance imaging[J].Arthritis Rheum,2010,62(4):940-951.
[16]	Wang J,Shi K,Xu HY,et al.Left ventricular deformation in patients with connective tissue disease:evaluated by 3.0T cardiac magnetic resonance tissue tracking[J].Sci Rep,2019,9(1):17913.
[17]	Huber AT,Bravetti M,Lamy J,et al.Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping[J].J Cardiovasc Magn Reson,2018,20(1):11.
[18]	Singh JA,Woodard PK,Dávila-Román VG,et al.Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus:a preliminary report[J].Lupus,2005,14(2):137-144.
[19]	Mahrholdt H,Goedecke C,Wagner A,et al.Cardiovascular magnetic resonance assessment of human myocarditis:a comparison to histology and molecular pathology[J].Circulation,2004,109(10):1250-1258.
[20]	Zhang Y,Corona-Villalobos CP,Kiani AN,et al.Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus[J].Int J Cardiovasc Imaging,2015,31(2):389-397.
[21]	Verhaert D,Thavendiranathan P,Giri S,et al.Direct T2 quantification of myocardial edema in acute ischemic injury[J].JACC Cardiovasc Imaging,2011,4(3):269-278.
[22]	Jiang L,Wang J,Liu X,et al.The combined effects of cardiac geometry,microcirculation,and tissue characteristics on cardiac systolic and diastolic function in subclinical diabetes mellitus-related cardiomyopathy[J].Int J Cardiol,2020,320:112-118.
[23]	Liu X,Yang ZG,Gao Y,et al.Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion:a contrast-enhanced cardiovascular magnetic resonance study[J].Cardiovasc Diabetol,2018,17(1):139.
[24]	Rodríguez-Reyna TS,Morelos-Guzman M,Hernández-Reyes P,et al.Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography[J].Rheumatology(Oxford),2015,54(4):647-654.
[25]	Saygin D,Highland KB,Tonelli AR.Microvascular involvement in systemic sclerosis and systemic lupus erythematosus[J].Microcirculation,2019,26(3):e12440.
[26]	Vignaux O,Allanore Y,Meune C,et al.Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis[J].Ann Rheum Dis,2005,64(9):1268-1273.
[27]	Mavrogeni S,Koutsogeorgopoulou L,Markousis-Mavrogenis G,et al.Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus[J].Lupus,2018,27(4):564-571.
[28]	Huber AT,Lamy J,Bravetti M,et al.Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy(IIM)[J].Eur Radiol,2019,29(10):5139-5147.
[29]	Yu L,Sun J,Sun J,et al.Early detection of myocardial involvement by T1 mapping of cardiac MRI in idiopathic inflammatory myopathy[J].J Magn Reson Imaging,2018,48(2):415-422.